These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 23797577)
21. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome. Reuter SE; Martin JH Clin Pharmacokinet; 2016 Jul; 55(7):807-812. PubMed ID: 26883879 [TBL] [Abstract][Full Text] [Related]
23. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631 [TBL] [Abstract][Full Text] [Related]
24. Current pharmacotherapy options for cancer anorexia and cachexia. Macciò A; Madeddu C; Mantovani G Expert Opin Pharmacother; 2012 Dec; 13(17):2453-72. PubMed ID: 23072481 [TBL] [Abstract][Full Text] [Related]
25. A systematic review to establish health-related quality-of-life domains for intervention targets in cancer cachexia. Wheelwright SJ; Darlington AS; Hopkinson JB; Fitzsimmons D; White A; Johnson CD BMJ Support Palliat Care; 2016 Sep; 6(3):307-14. PubMed ID: 24943495 [TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633 [TBL] [Abstract][Full Text] [Related]
27. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS). LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527 [TBL] [Abstract][Full Text] [Related]
28. Update on the treatment of cancer cachexia. Nishie K; Nishie T; Sato S; Hanaoka M Drug Discov Today; 2023 Sep; 28(9):103689. PubMed ID: 37385369 [TBL] [Abstract][Full Text] [Related]
30. Cancer-associated anorexia and cachexia. Implications for drug therapy. Loprinzi CL; Goldberg RM; Burnham NL Drugs; 1992 Apr; 43(4):499-506. PubMed ID: 1377116 [TBL] [Abstract][Full Text] [Related]
31. The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study. Bar-Sela G; Zalman D; Semenysty V; Ballan E Integr Cancer Ther; 2019; 18():1534735419881498. PubMed ID: 31595793 [No Abstract] [Full Text] [Related]
32. Cancer anorexia/cachexia. Goldberg RM; Loprinzi CL Cancer Treat Res; 1999; 100():31-41. PubMed ID: 10645495 [No Abstract] [Full Text] [Related]
33. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749 [TBL] [Abstract][Full Text] [Related]
34. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of Anorexia Cancer Cachexia Syndrome and Potential Benefits of Traditional Medicine and Natural Herbs. Ming-Hua C; Bao-Hua Z; Lei Y Curr Pharm Biotechnol; 2016; 17(13):1147-1152. PubMed ID: 27758689 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials. Advani SM; Advani PG; VonVille HM; Jafri SH BMC Cancer; 2018 Nov; 18(1):1174. PubMed ID: 30482179 [TBL] [Abstract][Full Text] [Related]
37. [Pharmacological therapy of cancer anorexia-cachexia]. Cardona D Nutr Hosp; 2006 May; 21 Suppl 3():17-26. PubMed ID: 16768027 [TBL] [Abstract][Full Text] [Related]
38. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668 [TBL] [Abstract][Full Text] [Related]
39. Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G). Smith AB; Cocks K; Parry D; Taylor M Qual Life Res; 2014 Apr; 23(3):971-6. PubMed ID: 24097080 [TBL] [Abstract][Full Text] [Related]
40. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Maltoni M; Nanni O; Scarpi E; Rossi D; Serra P; Amadori D Ann Oncol; 2001 Mar; 12(3):289-300. PubMed ID: 11332139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]